Skip to main content

Table 3 AUC0–12 change from baseline

From: The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD

Parameter

BDP/F/G

BDP/F

AUC0–12 mean change

p value

AUC0–12 mean change

p value

FEV1 (mls)

320

(257, 384)

 < 0.0001

227

(163, 290)

 < 0.0001

FVC (mls)

524

(420, 627)

 < 0.0001

351

(248, 455)

 < 0.0001

FEF25–75% (L/sec)

0.112

(0.080, 0.144)

 < 0.0001

0.082

(0.050, 0.113)

 < 0.0001

sGaw (L/s/kPa/L)

0.310

(0.259, 0.362)

 < 0.0001

0.224

(0.172, 0.275)

 < 0.0001

Raw (kPa/L/s)

 − 0.298

(− 0.369, − 0.226)

 < 0.0001

 − 0.242

(− 0.313, − 0.170)

 < 0.0001

RV (mls)

 − 678

(− 847, − 509)

 < 0.0001

 − 558

(− 727, − 389)

 < 0.0001

IC (mls)

328

(219, 438)

 < 0.0001

289

(180, 399)

 < 0.0001

FRC (mls)

 − 468

(− 612, − 323)

 < 0.0001

 − 426

(− 571, − 282)

 < 0.0001

TLC (mls)

 − 136

(− 243, − 28)

0.0144

 − 132

(− 239, − 24)

0.0174

R5–R20 (kPa/L/s)

 − 0.165

(− 0.198, − 0.132)

 < 0.0001

 − 0.117

(− 0.150, − 0.084)

 < 0.0001

X5 (kPa/L/s)

0.208

(0.169, 0.248)

 < 0.0001

0.159

(0.120, 0.198)

 < 0.0001

∆X5 (kPa/L/s)

 − 0.207

(− 0.262, − 0.152)

 < 0.0001

 − 0.140

(− 0.195, − 0.085)

 < 0.0001

Fres (1/s)

 − 8.235

(− 10.108, − 6.363)

 < 0.0001

 − 5.600

(− 7.472, − 3.727)

 < 0.0001

AX (kPa/L)

 − 2.991

(− 3.614, − 2.368)

 < 0.0001

 − 2.228

(− 2.851, − 1.604)

 < 0.0001

  1. Data = mean (95% CI) change in day 5 AUC0– 12 from pre-randomisation baseline visit AUC0–12. All AUC0–12 values (day 5 and baseline) are relative to the pre-dose value at baseline